These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22084033)

  • 1. Human neural stem cell tropism to metastatic breast cancer.
    Zhao D; Najbauer J; Annala AJ; Garcia E; Metz MZ; Gutova M; Polewski MD; Gilchrist M; Glackin CA; Kim SU; Aboody KS
    Stem Cells; 2012 Feb; 30(2):314-25. PubMed ID: 22084033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use.
    Metz MZ; Gutova M; Lacey SF; Abramyants Y; Vo T; Gilchrist M; Tirughana R; Ghoda LY; Barish ME; Brown CE; Najbauer J; Potter PM; Portnow J; Synold TW; Aboody KS
    Stem Cells Transl Med; 2013 Dec; 2(12):983-92. PubMed ID: 24167321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase.
    Lim SH; Choi SA; Lee JY; Wang KC; Phi JH; Lee DH; Song SH; Song JH; Jin X; Kim H; Lee HJ; Lim I; Kim SU; Kim SK
    Cancer Gene Ther; 2011 Nov; 18(11):817-24. PubMed ID: 21869821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma.
    Gutova M; Shackleford GM; Khankaldyyan V; Herrmann KA; Shi XH; Mittelholtz K; Abramyants Y; Blanchard MS; Kim SU; Annala AJ; Najbauer J; Synold TW; D'Apuzzo M; Barish ME; Moats RA; Aboody KS
    Gene Ther; 2013 Feb; 20(2):143-50. PubMed ID: 22402322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme.
    Gutova M; Najbauer J; Chen MY; Potter PM; Kim SU; Aboody KS
    Curr Stem Cell Res Ther; 2010 Sep; 5(3):273-6. PubMed ID: 19951251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.
    Danks MK; Yoon KJ; Bush RA; Remack JS; Wierdl M; Tsurkan L; Kim SU; Garcia E; Metz MZ; Najbauer J; Potter PM; Aboody KS
    Cancer Res; 2007 Jan; 67(1):22-5. PubMed ID: 17210679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-treatment with therapeutic neural stem cells expressing carboxyl esterase and CPT-11 inhibit growth of primary and metastatic lung cancers in mice.
    Yi BR; Kim SU; Choi KC
    Oncotarget; 2014 Dec; 5(24):12835-48. PubMed ID: 25544747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-prodrug systems: carboxylesterase/CPT-11.
    Danks MK; Potter PM
    Methods Mol Med; 2004; 90():247-62. PubMed ID: 14657567
    [No Abstract]   [Full Text] [Related]  

  • 9. Human Neural Stem Cells Overexpressing a Carboxylesterase Inhibit Bladder Tumor Growth.
    Choi SS; Chi BH; Chang IH; Kim KD; Lee SR; Kim SU; Lee HJ
    Mol Cancer Ther; 2016 Jun; 15(6):1201-7. PubMed ID: 27009215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11.
    Wierdl M; Tsurkan L; Hyatt JL; Edwards CC; Hatfield MJ; Morton CL; Houghton PJ; Danks MK; Redinbo MR; Potter PM
    Cancer Gene Ther; 2008 Mar; 15(3):183-92. PubMed ID: 18188187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.
    Frank RT; Edmiston M; Kendall SE; Najbauer J; Cheung CW; Kassa T; Metz MZ; Kim SU; Glackin CA; Wu AM; Yazaki PJ; Aboody KS
    PLoS One; 2009 Dec; 4(12):e8314. PubMed ID: 20016813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-directed enzyme prodrug therapy for osteosarcoma: sensitization to CPT-11 in vitro and in vivo by adenoviral delivery of a gene encoding secreted carboxylesterase-2.
    Oosterhoff D; Witlox MA; van Beusechem VW; Haisma HJ; Schaap GR; Bras J; Kruyt FA; Molenaar B; Boven E; Wuisman PI; Pinedo HM; Gerritsen WR
    Mol Cancer Ther; 2003 Aug; 2(8):765-71. PubMed ID: 12939466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization.
    Rose WC; Marathe PH; Jang GR; Monticello TM; Balasubramanian BN; Long B; Fairchild CR; Wall ME; Wani MC
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):73-85. PubMed ID: 16228206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.
    Danks MK; Morton CL; Krull EJ; Cheshire PJ; Richmond LB; Naeve CW; Pawlik CA; Houghton PJ; Potter PM
    Clin Cancer Res; 1999 Apr; 5(4):917-24. PubMed ID: 10213229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Optimization and Enhanced Prodrug-Mediated Delivery Overcomes Camptothecin Resistance in High-Risk Solid Tumors.
    Nguyen F; Guan P; Guerrero DT; Kolla V; Naraparaju K; Perry LM; Soberman D; Pressly BB; Alferiev IS; Chorny M; Brodeur GM
    Cancer Res; 2020 Oct; 80(19):4258-4265. PubMed ID: 32839252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma.
    Gutova M; Goldstein L; Metz M; Hovsepyan A; Tsurkan LG; Tirughana R; Tsaturyan L; Annala AJ; Synold TW; Wan Z; Seeger R; Anderson C; Moats RA; Potter PM; Aboody KS
    Mol Ther Oncolytics; 2017 Mar; 4():67-76. PubMed ID: 28345025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.
    Chao P; Deshmukh M; Kutscher HL; Gao D; Rajan SS; Hu P; Laskin DL; Stein S; Sinko PJ
    Anticancer Drugs; 2010 Jan; 21(1):65-76. PubMed ID: 19966540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker.
    Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL
    Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38.
    Stubdal H; Perin N; Lemmon M; Holman P; Bauzon M; Potter PM; Danks MK; Fattaey A; Dubensky T; Johnson L
    Cancer Res; 2003 Oct; 63(20):6900-8. PubMed ID: 14583489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.
    Seo GM; Rachakatla RS; Balivada S; Pyle M; Shrestha TB; Basel MT; Myers C; Wang H; Tamura M; Bossmann SH; Troyer DL
    Mol Biol Rep; 2012 Jan; 39(1):157-65. PubMed ID: 21567204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.